Global NASH/MASH Council (GNC) Meeting at INASL 2025 Annual Conference
The Global NASH/MASH Council (GNC) convened a highly productive meeting during the 33rd Annual Conference of the Indian National Association for the Study of the Liver (INASL), held August 7–10, 2025, in Chandigarh, India. Focusing on the impact of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) in South and Southeast Asia,...Continue reading→
Dimer Diabetes 2025, Bodrum, Turkey (October 26-29)
The Global NASH/MASH Council is delighted to collaborate with Dimer Diabetes 2025 which is a scientific meeting in Bodrum, Turkey with exceptional faculty and agenda. For more information about Dimer Diabetes 2025, please use the following link. https://www.dimerdiabetescenter.com/
The Global NASH/MASH and Global Liver Council Meetings During ILC 2025 in Amsterdam
GNC and GLC had another very successful meeting during ILC 2025 with over 70 members participating. The meeting was full of exciting reports related to the projects of different GNC/GLC committees. Additionally, an in-depth 3 hours meeting was dedicated to MASLD/SLD discussing NIT algorithms in clinical practice, awareness challenges, patient perspective about MASLD, preventive hepatology...Continue reading→
Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis, Gastroenterology, April 11, 2025
The Global NASH/MASH Council (GNC) has just published in Gastroenterology (April 11, 2025, In Press) the most comprehensive recommendations about MASLD and MASH. After systematically reviewing 61 guidelines and similar documents (2018-2025) and undertaking an extensive Delphi process, the Global Recommendations for MASLD/MASH provide the most updated clinically relevant information on all aspects of MASLD/MASH including risk...Continue reading→
The Global NASH Council Meeting During APASL 2025, Beijing, China March 27, 2025
The Global NASH/MASH Council (GNC) meeting was held during APASL 2025 in Beijing, China. The meeting was co-chaired by Professor Zobair M. Younossi and Professor Jiangao Fan and was attended by over 50 members in person and another 12 via zoom. A number of important topics related to the disease burden, NITs, risk stratification and...Continue reading→
Multidisciplinary management of patients with MASH
Multidisciplinary management of patients with MASH discussed by Drs Zobair Younossi, Manal Abdelmalek, Christos Montzoros, Mandeep Bajaj and Scott Issacs during the MASH session of Liver Connect 2025.
Kicking off the 5th Annual Liver Connect meeting in San Antonio Texas
Today, Dr. Zobair Younossi, Chairman of Global NASH/ MASH Council and President of Chronic Liver Disease Foundation kicked off the 5th Annual Liver Connect meeting in San Antonio Texas. Liver Connect has become a highly popular liver meeting in the US with over 500 attendees.
The Fifth Annual Liver Connect, San Antonio, Texas (March 20-22,2025)
The Fifth Annual Liver Connect is being organized by Chronic Liver Disease Foundation (CLDF) in San Antonio, Texas (March 20-22,2025). This superb meeting covers cutting-edge information about most common liver diseases (MASH, viral hepatitis, ALD, cholestatic liver disease, complications of cirrhosis, HCC and pediatric liver disease) delivered by internationally renowned experts. The meeting will provide an opportunity...Continue reading→
Focused Recommendations for the Management of Metabolic Dysfunction-Associated Steatohepatitis (MASH) by Advanced Practice Providers in the United States
The first APP guidance document for APPs is now fully published by members of the APP Committee of the Global NASH/MASH Council. This article provides a very practical and easy to use approach about MASH that can be used in everyday clinical practice.
International Liver Meeting, Paris, France, 2026
Save the date for the First Paris International Liver Meeting organized by highly recognized leaders in hepatology.
